OrsoBio’s experimental oral drug TLC-6740, when paired with the established GLP-1/GIP receptor agonist tirzepatide, has delivered encouraging early clinical results…
A small but startling new study reveals how Tirzepatide may quiet intense food cravings at least for a while. The…
If you’ve been following the wave of GLP‑1 and related weight‑management medications across the UK, you might have come across…
A recent analysis of patients treated with tirzepatide suggests that the medication’s favourable effects on the heart are similar whether…
A new analysis of the large SURMOUNT-1 study suggests that the drug Tirzepatide, already used for weight management , significantly…
Pharmaceuticals giant Eli Lilly and Company has announced a reduction in the cash price of its obesity drug Zepbound (tirzepatide)…
A new analysis has found that the once-weekly injectable drug Tirzepatide , already known for weight loss , may significantly…
A recent prespecified analysis of the SURPASS-CVOT trial suggests that Tirzepatide may offer better cardiovascular protection , including reductions in…
With GLP-1 weight-loss drugs like Wegovy (semaglutide) and Mounjaro (tirzepatide) attracting growing demand, private providers such as SheMed and MedExpress…
A pioneering human study reports that the medication Tirzepatide (used for type 2 diabetes and obesity) may suppress a key…
